Total Payments
$991.44
2024 Payments
$112.19
Companies
15
Transactions
54
Medicare Patients
3,644
Medicare Billing
$431,346
Payment Breakdown by Category
Food & Beverage$915.99 (92.4%)
Education$75.45 (7.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $915.99 | 53 | 92.4% |
| Education | $75.45 | 1 | 7.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $147.30 | 9 | $0 (2022) |
| Genentech USA, Inc. | $129.20 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $127.12 | 8 | $0 (2021) |
| Mylan Specialty L.P. | $111.77 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $107.13 | 8 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $103.67 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $75.45 | 1 | $0 (2023) |
| Baxter Healthcare | $54.13 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.07 | 2 | $0 (2023) |
| Advanced Respiratory, Inc | $28.61 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112.19 | 4 | JAZZ PHARMACEUTICALS INC. ($71.97) |
| 2023 | $142.54 | 4 | Regeneron Healthcare Solutions, Inc. ($75.45) |
| 2022 | $61.97 | 4 | GlaxoSmithKline, LLC. ($35.77) |
| 2021 | $34.10 | 2 | AstraZeneca Pharmaceuticals LP ($21.02) |
| 2020 | $60.63 | 4 | AstraZeneca Pharmaceuticals LP ($60.63) |
| 2019 | $144.67 | 8 | Mylan Specialty L.P. ($72.19) |
| 2018 | $186.78 | 12 | Novartis Pharmaceuticals Corporation ($56.21) |
| 2017 | $248.56 | 16 | GlaxoSmithKline, LLC. ($76.47) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: NEUROLOGY | ||||||
| 07/31/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $38.07 | General |
| Category: NEUROLOGY | ||||||
| 03/04/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Airway Clearance Device | ||||||
| 11/22/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROLOGY | ||||||
| 06/07/2023 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $36.13 | General |
| Category: Airway Clearance Device | ||||||
| 04/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: RESPIRATORY | ||||||
| 01/06/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $75.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2022 | Teva Pharmaceuticals USA, Inc. | ProAir Digihaler (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Respiratory | ||||||
| 11/11/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 08/24/2022 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $13.70 | General |
| Category: Neurological Disorders | ||||||
| 09/01/2021 | Philips Electronics North America Corporation | (2791) CoughAssist (Device) | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: Medical Device | ||||||
| 06/11/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Respiratory | ||||||
| 12/16/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Respiratory | ||||||
| 10/15/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Respiratory | ||||||
| 09/14/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Respiratory | ||||||
| 08/28/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Respiratory | ||||||
| 07/09/2019 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Respiratory and Allergy | ||||||
| 06/25/2019 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2019 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Respiratory and Allergy | ||||||
| 05/07/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Respiratory | ||||||
| 04/23/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Immunology | ||||||
| 03/27/2019 | Astellas Pharma US Inc | CRESEMBA (Drug), AMBISOME, MYCAMINE | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/19/2019 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Respiratory and Allergy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 807 | 1,228 | $356,950 | $84,024 |
| 2022 | 14 | 926 | 1,431 | $407,428 | $96,735 |
| 2021 | 15 | 914 | 1,533 | $482,061 | $115,269 |
| 2020 | 16 | 997 | 1,700 | $720,168 | $135,318 |
Total Patients
3,644
Total Services
5,892
Medicare Billing
$431,346
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 224 | $73,959 | $19,857 | 26.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 103 | 293 | $59,655 | $17,276 | 29.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 38 | 99 | $67,789 | $15,608 | 23.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 60 | $34,048 | $7,784 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 61 | 103 | $15,790 | $6,916 | 43.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 63 | $17,546 | $5,606 | 32.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 32 | 33 | $24,037 | $2,817 | 11.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,520 | $2,183 | 22.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 20 | 20 | $18,630 | $1,575 | 8.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,091 | $990.10 | 32.0% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 29 | 29 | $12,280 | $893.97 | 7.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 84 | 84 | $3,949 | $743.82 | 18.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 86 | 86 | $2,862 | $554.79 | 19.4% |
| 94375 | Test to measure rate of airflow | Facility | 2023 | 41 | 41 | $2,292 | $444.44 | 19.4% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 11 | 17 | $1,546 | $439.45 | 28.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 46 | 46 | $9,956 | $336.11 | 3.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 239 | $74,067 | $21,701 | 29.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 115 | 346 | $72,388 | $18,553 | 25.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 47 | 99 | $65,451 | $15,711 | 24.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 82 | 86 | $48,877 | $12,787 | 26.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 69 | 111 | $30,457 | $8,538 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 62 | 107 | $16,403 | $7,002 | 42.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 29 | 31 | $28,707 | $2,574 | 9.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $10,206 | $2,212 | 21.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 19 | 19 | $15,420 | $1,750 | 11.3% |
About Dr. Florin Stuleanu, M.D
Dr. Florin Stuleanu, M.D is a Pulmonary Disease healthcare provider based in Cudahy, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316958705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Florin Stuleanu, M.D has received a total of $991.44 in payments from pharmaceutical and medical device companies, with $112.19 received in 2024. These payments were reported across 54 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($915.99).
As a Medicare-enrolled provider, Stuleanu has provided services to 3,644 Medicare beneficiaries, totaling 5,892 services with total Medicare billing of $431,346. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Cudahy, WI
- Active Since 08/10/2006
- Last Updated 02/15/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1316958705
Products in Payments
- Xolair (Biological) $129.20
- XOLAIR (Biological) $107.13
- TRELEGY ELLIPTA (Drug) $93.40
- XYWAV (Drug) $87.33
- DUPIXENT (Biological) $75.45
- Yupelri (Drug) $72.19
- BEVESPI AEROSPHERE (Drug) $45.47
- BREZTRI AEROSPHERE (Drug) $43.25
- Hillrom - Life 2000 Ventilation System (Device) $36.13
- The Vest System Model 105 Home Care (Device) $28.61
- BREO (Drug) $27.98
- ANORO (Drug) $25.92
- YUPELRI (Drug) $22.22
- Arikayce (Drug) $21.74
- BREZTRI (Drug) $21.02
- Hillrom - Monarch Airway Clearance System (Device) $18.00
- SYMBICORT (Drug) $17.38
- Perforomist (Drug) $17.36
- Xyrem (Drug) $16.34
- CRESEMBA (Drug) $15.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Cudahy
Dr. Mathew Mathai, M.d, M.D
Pulmonary Disease — Payments: $47,851
Pulmonary Disease $47,851
Dr. Arturo Eyzaguirre, Md, MD
Pulmonary Disease — Payments: $487.77
Pulmonary Disease $487.77
Ajitkumar Parekh, Md, MD
Pulmonary Disease — Payments: $173.04
Pulmonary Disease $173.04
Dr. George Mathai, Md, MD
Pulmonary Disease — Payments: $16.77
Pulmonary Disease $16.77